Grandfield & Dodd’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
18,750
+38
| +0.2% | +$2.09K | 0.06% | 106 |
|
|
2025
Q1 | $1.32M | Buy |
18,712
+1,320
| +8% | +$93.3K | 0.08% | 98 |
|
|
2024
Q4 | $1.14M | Buy |
17,392
+731
| +4% | +$48K | 0.07% | 104 |
|
|
2024
Q3 | $1.17M | Buy |
16,661
+425
| +3% | +$29.9K | 0.07% | 102 |
|
|
2024
Q2 | $1.34M | Buy |
16,236
+109
| +0.7% | +$8.97K | 0.08% | 98 |
|
|
2024
Q1 | $1.41M | Buy |
16,127
+255
| +2% | +$22.3K | 0.09% | 97 |
|
|
2023
Q4 | $1.53M | Buy |
15,872
+219
| +1% | +$21.1K | 0.11% | 91 |
|
|
2023
Q3 | $1.38M | Sell |
15,653
-125
| -0.8% | -$11.1K | 0.1% | 91 |
|
|
2023
Q2 | $1.37M | Buy |
15,778
+137
| +0.9% | +$11.9K | 0.1% | 91 |
|
|
2023
Q1 | $1.52M | Buy |
15,641
+231
| +1% | +$22.5K | 0.11% | 87 |
|
|
2022
Q4 | $1.59M | Buy |
15,410
+1,037
| +7% | +$107K | 0.12% | 85 |
|
|
2022
Q3 | $1.22M | Buy |
14,373
+372
| +3% | +$31.6K | 0.1% | 91 |
|
|
2022
Q2 | $1.16M | Buy |
14,001
+75
| +0.5% | +$6.21K | 0.09% | 91 |
|
|
2022
Q1 | $1.07M | Buy |
13,926
+456
| +3% | +$35K | 0.07% | 99 |
|
|
2021
Q4 | $1.19M | Buy |
13,470
+1,337
| +11% | +$118K | 0.08% | 93 |
|
|
2021
Q3 | $940K | Buy |
12,133
+399
| +3% | +$30.9K | 0.07% | 104 |
|
|
2021
Q2 | $980K | Buy |
11,734
+215
| +2% | +$18K | 0.07% | 100 |
|
|
2021
Q1 | $870K | Buy |
11,519
+280
| +2% | +$21.1K | 0.07% | 104 |
|
|
2020
Q4 | $990K | Buy |
11,239
+439
| +4% | +$38.7K | 0.08% | 100 |
|
|
2020
Q3 | $820K | Buy |
10,800
+167
| +2% | +$12.7K | 0.07% | 100 |
|
|
2020
Q2 | $1.31M | Buy |
10,633
+695
| +7% | +$85.6K | 0.13% | 81 |
|
|
2020
Q1 | $840K | Buy |
9,938
+525
| +6% | +$44.4K | 0.1% | 92 |
|
|
2019
Q4 | $796K | Buy |
9,413
+950
| +11% | +$80.3K | 0.07% | 107 |
|
|
2019
Q3 | $570K | Buy |
8,463
+930
| +12% | +$62.6K | 0.06% | 121 |
|
|
2019
Q2 | $645K | Buy |
7,533
+665
| +10% | +$56.9K | 0.06% | 116 |
|
|
2019
Q1 | $610K | Buy |
6,868
+112
| +2% | +$9.95K | 0.06% | 116 |
|
|
2018
Q4 | $575K | Buy |
6,756
+94
| +1% | +$8K | 0.07% | 112 |
|
|
2018
Q3 | $646K | Buy |
6,662
+70
| +1% | +$6.79K | 0.07% | 117 |
|
|
2018
Q2 | $621K | Buy |
6,592
+45
| +0.7% | +$4.24K | 0.07% | 117 |
|
|
2018
Q1 | $531K | Sell |
6,547
-240
| -4% | -$19.5K | 0.06% | 118 |
|
|
2017
Q4 | $605K | Buy |
6,787
+290
| +4% | +$25.9K | 0.06% | 121 |
|
|
2017
Q3 | $605K | Buy |
6,497
+650
| +11% | +$60.5K | 0.07% | 117 |
|
|
2017
Q2 | $531K | Buy |
5,847
+120
| +2% | +$10.9K | 0.06% | 125 |
|
|
2017
Q1 | $503K | Buy |
5,727
+65
| +1% | +$5.71K | 0.06% | 126 |
|
|
2016
Q4 | $469K | Buy |
5,662
+535
| +10% | +$44.3K | 0.06% | 126 |
|
|
2016
Q3 | $474K | Buy |
5,127
+280
| +6% | +$25.9K | 0.06% | 123 |
|
|
2016
Q2 | $377K | Buy |
4,847
+188
| +4% | +$14.6K | 0.05% | 132 |
|
|
2016
Q1 | $384K | Buy |
4,659
+1,785
| +62% | +$147K | 0.06% | 125 |
|
|
2015
Q4 | $301K | Buy |
2,874
+545
| +23% | +$57.1K | 0.05% | 144 |
|
|
2015
Q3 | $245K | Sell |
2,329
-183
| -7% | -$19.3K | 0.04% | 152 |
|
|
2015
Q2 | $344K | Sell |
2,512
-196
| -7% | -$26.8K | 0.05% | 134 |
|
|
2015
Q1 | $337K | Hold |
2,708
| – | – | 0.05% | 129 |
|
|
2014
Q4 | $245K | Buy |
+2,708
| New | +$245K | 0.04% | 150 |
|